Phase II trial of pre-operative stereotactic ablative radiotherapy (SABR) in early-stage breast cancer

被引:0
|
作者
Liveringhouse, C. L.
Diaz, R.
Ahmed, K. A.
Lee, M. C.
Czerniecki, B.
Laronga, C.
Khakpour, N.
Weinfurtner, R. J.
Rosa, M.
Montejo, M. E.
机构
[1] Univ S Florida, Coll Med, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
D O I
10.1158/1538-7445.SABCS18-OT2-04-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OT2-04-05
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Clinical stereotactic ablative body radiotherapy on patients with early-stage inoperable lung cancer
    Yeo, R.
    Nariyangadu, P.
    Shah, N.
    Tsang, Y.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S376 - S376
  • [42] Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer-A Done Deal?
    Gulstene, S.
    Ruwanpura, T.
    Palma, D.
    Joseph, N.
    CLINICAL ONCOLOGY, 2022, 34 (11) : 733 - 740
  • [43] Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay
    Ronden, Merle I.
    Palma, David
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 855 - 862
  • [44] Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
    Hanbo Chen
    Jussi Tikkanen
    R. Gabriel Boldt
    Alexander V. Louie
    Radiation Oncology, 13
  • [45] Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
    Chen, Hanbo
    Tikkanen, Jussi
    Boldt, R. Gabriel
    Louie, Alexander, V
    RADIATION ONCOLOGY, 2018, 13
  • [46] Pre-operative chemotherapy and radiotherapy in breast cancer
    Colleoni, M
    Nole, F
    Minchella, I
    Noberasco, C
    Luini, A
    Orecchia, A
    Veronesi, P
    Zurrida, S
    Viale, G
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) : 641 - 645
  • [47] Pre-Operative, Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer: Radiology-Pathology Correlation of Tumor Response in a Phase 2 Clinical Trial
    Reverberi, C.
    Prisco, A.
    Facondo, G.
    Moretti, E.
    Scalchi, P. S.
    Orsaria, M.
    Pegolo, E.
    Di Loreto, C.
    Zuiani, C.
    Seriau, L.
    Bertozzi, S.
    Cedolini, C.
    Trovo, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E337 - E337
  • [48] PEARL: Pathologic Effect of NeoAdjuvant Stereotactic Ablative Body Radiotherapy (SABR) in Operable Early Stage Lung Cancer
    Van Meerbeeck, Jan P.
    Vandecasteele, Katrien
    Tournoy, Kurt
    Vermaelen, Karim Y.
    De Ryck, Frederic
    Surmont, Veerle F.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S680 - S680
  • [49] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [50] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447